본문 바로가기
KERD
논문KCI 등재

Inhibin-A를 추가한 Quad Test의 한국인 산모의 임신주수별 Median치에 대한 평가

Evaluation of Gestational Age Median Value by Use of the Quad Test with Dimeric Inhibin A for Korea Pregnant Women

1

조회

0

다운로드

0

인용

0

참고문헌

키워드

주제분류기타자연과학

초록

.

Abstract

Human chorionic gonadotrophin (hCG) and unconjugated estriol (uE3) were added to AFP to make what is commonly known as the Triple test. The Triple test combines results from these three tests and has been a standard screening procedure for several years. Recent studies have demonstrated the usefulness of adding inhibin-A to Down's syndrome risk assessment. The Quad test adds dimeric Inhibin-A (DIA) to the three other markers and uses the same computer program to calculate risk factors. Testing was performed between 14 and 21 weeks of gestation. Sample size were 648 samples and period of study was from 1, July, 2004 to 30, September, 2004. Used analytical methods for AFP, hCG and uE3 were radioimmunoassay (RIA) and dimeric inhibin A was enzyme-linked immunosorbent assay (ELISA). Adding dimeric inhibin-A as a fourth marker to the standard triple test increases the detection rate from 62 % to 75 % with a false-positive rate of 5%. The DIA based Quad test has been shown to be the most effective second trimester screening test for Down's syndrome suitable for routine use. Increased DIA values are observed during normal pregnancy where a bimodal pattern response is seen. Values increase during the first trimester, decline after 14 weeks, and re-ascend between 17-25 weeks. Values for DIA may be additionally elevated during a Down's syndrome pregnancy. Dimeric inhibin A is a glycoprotein hormone made by the ovary and placenta. DIA levels are twice as high in Down‘s syndrome pregnancies. AFP, hCG, and uE3 levels vary with gestational age, and incorrect gestational dating will influence results. DIA levels do not vary substantially with gestational age, resulting in greater screening accuracy. Although the Quad test is an improvement over the Triple test, it is important to underscore the fact that a positive test on both should be done. Most women who initially screen positive will be found to be carrying normal babies when amniocentesis and definitive diagnostic chromosome analysis are done.

관련 논문AI추천

불량한 임신 결과 예측을 위한 임신중기 산모 혈청 inhibin-A 측정의 연관성김석영, 김정민, 손유경, 오현명, 이경훈, 이순표대한산부인과학회 · Obstetrics & Gynecology Science2008 · 제51권 제11호Performance Characteristics of the UniCel DxI 800 Immunoassay for the Maternal Serum Quadruple Test, Including Median Values for Each Week of Gestation, in Korean Women권오헌, 김정호, 박용정, 서보름, 송선미, 이정훈대한진단검사의학회 · Annals of Laboratory Medicine2010 · 제30권 제2호다운 증후군과 임신 합병증에서 임신 제 2삼분기 양수내Activin A, Inhibin A와 B의 농도와 이들 비율의 의의이영, 김수평, 김용욱, 나종구, 류상우, 류영옥, 신종철, 이종건대한산부인과학회 · Obstetrics & Gynecology Science2004 · 제47권 제6호국내 생화학적 표지자 산전선별검사 기초조사 보고김솔잎, 김윤희, 민원기대한진단검사의학회 · Annals of Laboratory Medicine2007 · 제27권 제1호임신 초기 임신양상에 따른 혈청 β-hCG의 결과 예측에 의한 희석배수 참고치 설정김윤식, 서영미, 신장용, 유신수대한임상검사과학회 · 대한임상검사과학회지2004 · 제36권 제2호모체 혈청내의 Unconjugaud Estriol의 측정 시약간의 임신 주수별 측정치 분석김미숙, 유자영, 이규현, 최삼규대한임상검사과학회 · 대한임상검사과학회지1998 · 제30권 제3호

이 간행물의 다른 논문 (8건)